These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2941765)

  • 21. [SMON syndrome. First case after abuse of a methylated hydroxyquinoline derivative].
    Saragoussi JJ; Soffer M; Giraud D; Raison J; Basdevant A; Pouliquen Y
    Bull Soc Ophtalmol Fr; 1984 Jan; 84(1):25-8. PubMed ID: 6442219
    [No Abstract]   [Full Text] [Related]  

  • 22. Subacute myelo-optico-neuropathy (SMON) and clioquinol: -A response to doubts about clioquinol causation theory-.
    Shigematsu I
    Jpn J Med Sci Biol; 1975; 28 Suppl():35-55. PubMed ID: 136540
    [No Abstract]   [Full Text] [Related]  

  • 23. The neurotoxicity of the halogenated hydroxyquinolines. A commentary.
    Oakley GP
    JAMA; 1973 Jul; 225(4):395-7. PubMed ID: 4270059
    [No Abstract]   [Full Text] [Related]  

  • 24. Idiosyncratic neurotoxicity: clioquinol and bismuth.
    Lancet; 1980 Apr; 1(8173):857-8. PubMed ID: 6103216
    [No Abstract]   [Full Text] [Related]  

  • 25. [Subacute myelo-optic-neuropathy during treatment with chloro-iodo-hydroxyquinoleine (author's transl)].
    Charasz N; Vacherot B; Dougados M; Bousser MG; Belaiche J; Cattan D
    Gastroenterol Clin Biol; 1979 Apr; 3(4):371-4. PubMed ID: 159200
    [No Abstract]   [Full Text] [Related]  

  • 26. Clioquinol and S.M.O.N.: Reanalysis of original data.
    Asao M
    Lancet; 1979 Feb; 1(8113):446. PubMed ID: 84300
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neurotoxicity of chinoform].
    Iwashita H
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):602-5. PubMed ID: 10434730
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neurotoxic symptoms following clioquinol (Enterovioform)].
    Pannekoek JH
    Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1611-5. PubMed ID: 4262824
    [No Abstract]   [Full Text] [Related]  

  • 29. Relation between subacute myelo-optic neuropathy (S.M.O.N.) and clioquinol: nationwide survey.
    Nakae K; Yamamoto S; Shigematsu I; Kono R
    Lancet; 1973 Jan; 1(7796):171-3. PubMed ID: 4118793
    [No Abstract]   [Full Text] [Related]  

  • 30. [Subacute myelo-optico-neuropathy following use of large amounts of iodochlorhydroxyquinoline (Enterovioform)].
    Bron HL; Korten JJ; Pinckers AJ; Majoor CL
    Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1615-8. PubMed ID: 4262825
    [No Abstract]   [Full Text] [Related]  

  • 31. Peripheral neuropathy in rats fed with clioquinol.
    Jones EL; Searle CE; Smith WT
    J Pathol; 1972 Jul; 107(3):P8-9. PubMed ID: 4263803
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serious sensory-motor neuropathy. A case of renal failure following clioquinol absorption].
    Gendre JP; Barbanel C; Degos JD; Le Quintrec Y
    Nouv Presse Med; 1974 Nov; 3(37):2395-8. PubMed ID: 4282135
    [No Abstract]   [Full Text] [Related]  

  • 33. [A iatrogenic disease... subacute myelo-optico-neuropathy].
    Degos CF; Thomas-Lamotte PJ
    Rev Prat; 1977 Jun; 27(35):2277-85. PubMed ID: 143057
    [No Abstract]   [Full Text] [Related]  

  • 34. Zinc deficiency, acrodermatitis enteropathica, optic atrophy, subacute myelo-optic neuropathy, and 5,7-dihalo-8-quinolinols.
    Sturtevant FM
    Pediatrics; 1980 Mar; 65(3):610-3. PubMed ID: 6444713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myelo-optic neuropathy induced by clioquinol in animals.
    Tateishi J; Kuroda S; Saito A; Otsuki S
    Lancet; 1971 Dec; 2(7736):1263-4. PubMed ID: 4143622
    [No Abstract]   [Full Text] [Related]  

  • 36. [Case of subacute myelo-optico-neuropathy].
    Mackiewicz J; Wendorff J
    Neurol Neurochir Pol; 1980; 14(1):121-3. PubMed ID: 6445513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clioquinol's return: cautions from Japan.
    Tabira T
    Science; 2001 Jun; 292(5525):2251-2. PubMed ID: 11424945
    [No Abstract]   [Full Text] [Related]  

  • 38. [Subacute myelopathy during a course of treatment with clioquinol in a patient colectomized for Crohn's disease].
    Fabiani F; Pompili A; Scarinci A; Sinibaldi L
    Riv Neurobiol; 1978; 24(1-2):121-37. PubMed ID: 161413
    [No Abstract]   [Full Text] [Related]  

  • 39. Oxyquinoline neurotoxicity.
    Guy-Grand B; Basdevant A; Soffer M
    Lancet; 1983 Apr; 1(8331):933. PubMed ID: 6132266
    [No Abstract]   [Full Text] [Related]  

  • 40. Subacute myelo-optico-neuropathy (SMON).
    Nelson E
    Ann Intern Med; 1972 Sep; 77(3):468-70. PubMed ID: 4262315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.